Cytokinetics | CYTK - Market Capitalization


Cytokinetics reported $6.34B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Amgen USD 247.94B 20.06B Nov/2026
Arca Biopharma USD 2.43B 963M Mar/2026
Bayer EUR 52.42B 5.31B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cytokinetics USD 7.51B 1.66B Nov/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Exelixis USD 19.82B 5.34B Nov/2026
Geron USD 653M 137M Nov/2026
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Ionis Pharmaceuticals USD 5.75B 7.35B Nov/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 165.52B 2.11B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026